BHST.US BioHarvest Sciences Inc. Common Stock

Consumer Defensive Personal Care Products USA Stocks
1.51 USD
Close of Nov 14, 2026
1.37 7.60
Market cap
USD 34.1M
P/E
-
P/B
1.87x
ROE
-76.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BHST.US undervalued?

Graham number

The Graham number of BioHarvest Sciences Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioHarvest Sciences Inc. Common Stock fundamental analysis

No fundamental analysis for BioHarvest Sciences Inc. Common Stock yet.

BioHarvest Sciences Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supple…

Full company profile